Avior Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Avior Wealth Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-233	Closed	-$3.67K	–	3894
2024 Q1	$3.67K	Buy	+233	New	+$3.59K	﹤0.01%	2162

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Avior Wealth Management's DCPH Position: Q2 2024 in Review

Avior Wealth Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 233 shares — an estimated $3.67K sold.

Avior Wealth Management first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $3.67K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Avior Wealth Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Avior Wealth Management sold 233 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.67K.
Avior Wealth Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Avior Wealth Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.67K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.